Pharvaris

About Pharvaris

Pharvaris is a Nasdaq listed late-stage biotech company focused on developing bradykinin B2 receptor antagonists for the treatment of bradykinin-mediated angioedema, including hereditary angioedema. With offices in Switzerland, the Netherlands, and the USA, the company aims to provide new and more convenient options for individuals suffering from sudden and prolonged attacks of swelling, which can be life-threatening.

Career Opportunities

Pharvaris offers a dynamic working environment where employees are encouraged to contribute freely and lead with trust. The company values diversity of thought and is committed to professional growth, making it an ideal place for individuals looking to make a meaningful impact in the biotech industry.

• Opportunity to work on breakthrough therapies
• Supportive and inclusive company culture
• Remote work flexibility